Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Advances in dyslipidemia management for prevention of atherosclerosis: PCSK9 monoclonal antibody therapy and beyond.

Wong ND, Rosenblit PD, Greenfield RS.

Cardiovasc Diagn Ther. 2017 Apr;7(Suppl 1):S11-S20. doi: 10.21037/cdt.2017.03.02. Review.

2.

Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.

Banach M, Rizzo M, Toth PP, Farnier M, Davidson MH, Al-Rasadi K, Aronow WS, Athyros V, Djuric DM, Ezhov MV, Greenfield RS, Hovingh GK, Kostner K, Serban C, Lighezan D, Fras Z, Moriarty PM, Muntner P, Goudev A, Ceska R, Nicholls SJ, Broncel M, Nikolic D, Pella D, Puri R, Rysz J, Wong ND, Bajnok L, Jones SR, Ray KK, Mikhailidis DP.

Expert Opin Drug Saf. 2015 Jun;14(6):935-55. doi: 10.1517/14740338.2015.1039980. Epub 2015 Apr 24.

PMID:
25907232
3.

Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.

Banach M, Rizzo M, Toth PP, Farnier M, Davidson MH, Al-Rasadi K, Aronow WS, Athyros V, Djuric DM, Ezhov MV, Greenfield RS, Hovingh GK, Kostner K, Serban C, Lighezan D, Fras Z, Moriarty PM, Muntner P, Goudev A, Ceska R, Nicholls SJ, Broncel M, Nikolic D, Pella D, Puri R, Rysz J, Wong ND, Bajnok L, Jones SR, Ray KK, Mikhailidis DP.

Arch Med Sci. 2015 Mar 16;11(1):1-23. doi: 10.5114/aoms.2015.49807. Epub 2015 Mar 14.

4.

Detection and quantification of thrombomodulin in human semen.

Lwaleed BA, Greenfield RS, Cooper AJ.

Blood Coagul Fibrinolysis. 2008 Mar;19(2):142-5. doi: 10.1097/MBC.0b013e3282f44e54.

PMID:
18277135
5.

Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.

Jankun J, Aleem AM, Selman SH, Skrzypczak-Jankun E, Lysiak-Szydlowska W, Grafos N, Fryer HJ, Greenfield RS.

Int J Mol Med. 2007 Nov;20(5):683-7.

PMID:
17912461
6.

Seminal thrombin-activatable fibrinolysis inhibitor: a regulator of liquefaction.

Lwaleed BA, Goyal A, Greenfield RS, Cooper AJ.

Blood Coagul Fibrinolysis. 2007 Jul;18(5):449-54.

PMID:
17581319
7.

Seminal factor VII and factor VIIa: supporting evidence for the presence of an active tissue factor-dependent coagulation pathway in human semen.

Lwaleed BA, Goyal A, Delves G, Gossai S, Greenfield RS, Cooper AJ.

Int J Androl. 2007 Dec;30(6):543-9. Epub 2007 Apr 24.

PMID:
17459125
8.

ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.

Tsai HM, Raoufi M, Zhou W, Guinto E, Grafos N, Ranzurmal S, Greenfield RS, Rand JH.

Thromb Haemost. 2006 May;95(5):886-92.

9.
11.
12.

Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates.

Trail PA, Willner D, Knipe J, Henderson AJ, Lasch SJ, Zoeckler ME, TrailSmith MD, Doyle TW, King HD, Casazza AM, Braslawsky GR, Brown J, Hofstead SJ, Greenfield RS, Firestone RA, Mosure K, Kadow KF, Yang MB, Hellström KE, Hellström I.

Cancer Res. 1997 Jan 1;57(1):100-5.

13.

Granulocyte-macrophage colony-stimulating factor plays a role in the functional activity of mast cells.

Meade R, Neddermann KM, Greenfield RS, Braslawsky G, Bursuker I.

J Leukoc Biol. 1993 Dec;54(6):523-7.

PMID:
8245704
14.

(6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicin.

Willner D, Trail PA, Hofstead SJ, King HD, Lasch SJ, Braslawsky GR, Greenfield RS, Kaneko T, Firestone RA.

Bioconjug Chem. 1993 Nov-Dec;4(6):521-7.

PMID:
7508268
15.

Identification of functional domains in murine granulocyte-macrophage colony-stimulating factor using monoclonal antibodies to synthetic peptides.

Greenfield RS, Braslawsky GR, Kadow KF, Spitalny GL, Chace D, Bull CO, Bursuker I.

J Immunol. 1993 Jun 15;150(12):5241-51.

PMID:
8515057
16.

Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models.

Trail PA, Willner D, Lasch SJ, Henderson AJ, Greenfield RS, King D, Zoeckler ME, Braslawsky GR.

Cancer Res. 1992 Oct 15;52(20):5693-700.

17.

New hydrazone derivatives of adriamycin and their immunoconjugates--a correlation between acid stability and cytotoxicity.

Kaneko T, Willner D, Monkovíc I, Knipe JO, Braslawsky GR, Greenfield RS, Vyas DM.

Bioconjug Chem. 1991 May-Jun;2(3):133-41.

PMID:
1932212
18.

Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity.

Braslawsky GR, Kadow K, Knipe J, McGoff K, Edson M, Kaneko T, Greenfield RS.

Cancer Immunol Immunother. 1991;33(6):367-74.

PMID:
1878890
19.

Homodimeric forms of bombesin act as potent antagonists of bombesin on Swiss 3T3 cells.

Gawlak SL, Kiener PA, Braslawsky GR, Greenfield RS.

Growth Factors. 1991;5(2):159-70.

PMID:
1662974
20.

Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killing.

Braslawsky GR, Edson MA, Pearce W, Kaneko T, Greenfield RS.

Cancer Res. 1990 Oct 15;50(20):6608-14.

21.

Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker.

Greenfield RS, Kaneko T, Daues A, Edson MA, Fitzgerald KA, Olech LJ, Grattan JA, Spitalny GL, Braslawsky GR.

Cancer Res. 1990 Oct 15;50(20):6600-7.

22.

Immunohistochemical and biochemical characterization of antisera raised to human tumor nucleoli.

Greenfield RS, Lamon MO, Olech LJ, Grattan JA.

J Cancer Res Clin Oncol. 1989;115(4):351-60.

PMID:
2503520
23.

Antibodies to the common leukocyte antigen (T200) inhibit an early phase in the activation of resting human B cells.

Mittler RS, Greenfield RS, Schacter BZ, Richard NF, Hoffmann MK.

J Immunol. 1987 May 15;138(10):3159-66.

PMID:
2952710
24.

Biochemical analysis and biological activities of immunoaffinity purified natural murine gamma interferon (MuIFN-gamma).

Greenfield RS, Kiener PA, Chin DP, Curry RC, Spitalny GL.

J Leukoc Biol. 1986 Dec;40(6):665-76.

PMID:
3097224
25.

Demonstration of unique and common antigenic sites located on the SV40 large T and small t antigens.

Greenfield RS, Flyer DC, Tevethia SS.

Virology. 1980 Jul 30;104(2):312-22. No abstract available.

PMID:
6156542
26.

SV40 transplantation antigen: relationship to SV40-specific proteins.

Tevethia SS, Greenfield RS, Flyer DC, Tevethia MJ.

Cold Spring Harb Symp Quant Biol. 1980;44 Pt 1,:235-42. No abstract available.

PMID:
6253137
27.

Use of radionuclides in coronary artery disease.

Greenfield RS, Aronow WS.

Compr Ther. 1979 Nov;5(11):56-67. No abstract available.

PMID:
509911
29.

L-Threonine deaminase as a possible antitumor agent.

Wellner D, Greenfield RS.

Cancer Treat Rep. 1979 Jun;63(6):1089-94.

PMID:
466649
30.

Biology of simian virus 40 (SV40) transplantation antigen (TrAg). IV. Inhibition by human interferon of expression of SV40 TrAg in SV40-infected monkey cells.

Tevethia SS, Greenfield RS, Rieder V, Tevethia MJ.

Virology. 1979 Jun;95(2):587-92. No abstract available.

PMID:
223293
31.

Effect of the vasodilator trimazosin versus placebo on exercise performance in chronic left ventricular failure.

Aronow WS, Greenfield RS, Alimadadian H, Danahy DT.

Am J Cardiol. 1977 Nov;40(5):789-93.

PMID:
335867
32.

Echocardiographic pseudoidiopathic hypertrophic subaortic stenosis in a patient with pericardial effusion.

Prakash R, Greenfield RS, Aronow WS.

J Clin Ultrasound. 1977 Oct;5(5):350-1.

PMID:
410844
33.

Follow-up technetium-99m stannous pyrophosphate myocardial scintigrams after acute myocardial infarction.

Olson HG, Lyons KP, Aronow WS, Brown WT, Greenfield RS.

Circulation. 1977 Aug;56(2):181-7.

PMID:
872308
34.

Supplemental Content

Loading ...
Support Center